A citation-based method for searching scientific literature

Michael J Hall, Julia E Reid, Lynn A Burbidge, Dmitry Pruss, Amie M Deffenbaugh, Cynthia Frye, Richard J Wenstrup, Brian E Ward, Thomas A Scholl, Walter W Noll. Cancer 2009
Times Cited: 220







List of co-cited articles
662 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
760
17

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
16

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
991
14

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
14

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
97
12

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016
234
12

Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors.
Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
81
14

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
11

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
11

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
195
10

A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.
Tuya Pal, Devon Bonner, Deborah Cragun, Alvaro N A Monteiro, Catherine Phelan, Lily Servais, Jongphil Kim, Steven A Narod, Mohammad R Akbari, Susan T Vadaparampil. Cancer 2015
50
20

Inherited predisposition to breast cancer among African American women.
Jane E Churpek, Tom Walsh, Yonglan Zheng, Zakiya Moton, Anne M Thornton, Ming K Lee, Silvia Casadei, Amanda Watts, Barbara Neistadt, Matthew M Churpek,[...]. Breast Cancer Res Treat 2015
79
12

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
331
10

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
10

Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
219
9

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
480
9

Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk.
Douglas E Levy, Stacey D Byfield, Catherine B Comstock, Judy E Garber, Sapna Syngal, William H Crown, Alexandra E Shields. Genet Med 2011
152
9

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
625
9

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
9

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
468
9

Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
72
12

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Jennifer K Litton, Hope S Rugo, Johannes Ettl, Sara A Hurvitz, Anthony Gonçalves, Kyung-Hun Lee, Louis Fehrenbacher, Rinat Yerushalmi, Lida A Mina, Miguel Martin,[...]. N Engl J Med 2018
546
9

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
289
8

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
354
8

Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
Allison W Kurian, Kent A Griffith, Ann S Hamilton, Kevin C Ward, Monica Morrow, Steven J Katz, Reshma Jagsi. JAMA 2017
68
11

Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
Jennifer L Caswell-Jin, Tanya Gupta, Evan Hall, Iva M Petrovchich, Meredith A Mills, Kerry E Kingham, Rachel Koff, Nicolette M Chun, Peter Levonian, Alexandra P Lebensohn,[...]. Genet Med 2018
53
15


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
817
8

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
165
8


Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies.
Anita Yeomans Kinney, Amanda Gammon, James Coxworth, Sara E Simonsen, Maritza Arce-Laretta. Genet Med 2010
60
11

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
299
7

Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.
Reshma Jagsi, Kent A Griffith, Allison W Kurian, Monica Morrow, Ann S Hamilton, John J Graff, Steven J Katz, Sarah T Hawley. J Clin Oncol 2015
57
12

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer.
Allison W Kurian, Yun Li, Ann S Hamilton, Kevin C Ward, Sarah T Hawley, Monica Morrow, M Chandler McLeod, Reshma Jagsi, Steven J Katz. J Clin Oncol 2017
125
7

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
249
7

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
285
7


Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
267
7

Uptake, Results, and Outcomes of Germline Multiple-Gene Sequencing After Diagnosis of Breast Cancer.
Allison W Kurian, Kevin C Ward, Ann S Hamilton, Dennis M Deapen, Paul Abrahamse, Irina Bondarenko, Yun Li, Sarah T Hawley, Monica Morrow, Reshma Jagsi,[...]. JAMA Oncol 2018
66
10

High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia.
Diana Torres, Muhammad Usman Rashid, Fabian Gil, Angela Umana, Giancarlo Ramelli, Jose Fernando Robledo, Mauricio Tawil, Lilian Torregrosa, Ignacio Briceno, Ute Hamann. Breast Cancer Res Treat 2007
67
8

The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective.
Julie Dutil, Volha A Golubeva, Alba L Pacheco-Torres, Hector J Diaz-Zabala, Jaime L Matta, Alvaro N Monteiro. Breast Cancer Res Treat 2015
43
13

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry.
Rita Nanda, L Philip Schumm, Shelly Cummings, James D Fackenthal, Lise Sveen, Foluso Ademuyiwa, Melody Cobleigh, Laura Esserman, Noralane M Lindor, Susan L Neuhausen,[...]. JAMA 2005
170
6

Disparities in genetic testing: thinking outside the BRCA box.
Michael J Hall, Olufunmilayo I Olopade. J Clin Oncol 2006
115
6

Awareness and preferences regarding BRCA1/2 genetic counseling and testing among Latinas and non-Latina white women at increased risk for hereditary breast and ovarian cancer.
Amanda Dawn Gammon, Erin Rothwell, Rebecca Simmons, Jan T Lowery, Lori Ballinger, Deirdre A Hill, Kenneth M Boucher, Anita Yeomans Kinney. J Genet Couns 2011
31
19

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
6

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014
206
6

Genetic Misdiagnoses and the Potential for Health Disparities.
Arjun K Manrai, Birgit H Funke, Heidi L Rehm, Morten S Olesen, Bradley A Maron, Peter Szolovits, David M Margulies, Joseph Loscalzo, Isaac S Kohane. N Engl J Med 2016
297
6

Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis.
Jeffrey N Weitzel, Sarah M McCaffrey, Raluca Nedelcu, Deborah J MacDonald, Kathleen R Blazer, Carey A Cullinane. Arch Surg 2003
116
6

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
6

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
128
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.